Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06355609
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2024-03-30
Brief Title:
Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW
Sponsor:
Hunan Province Tumor Hospital
Organization:
Hunan Province Tumor Hospital